A pan-cancer analysis revealed a trend toward a negative correlation between USP28 levels and the active form of DYRK2 across different tumor types (Fig. 1H), with high statistical significance primarily driven by lung adenocarcinoma (LUAD) (Fig. 1I). The gene discussed is DYRK2; the disease is lung adenocarcinoma.